An interventional study of TUI-1 and TUI-2 in Invasive Ventilation, sponsored by Fisher and Paykel Healthcare. Not yet recruiting at 1 site in New Zealand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-12.
Sponsored by Fisher and Paykel Healthcare · Not applicable, Interventional, and Other
The goal of this investigation is to examine the effect of nasal airflow in invasively ventilated adult patients following planned surgery. The main questions it aims to answer are:
Fisher and Paykel Healthcare is the lead sponsor of 86 studies on the registry; 16 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 10 (91%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Receipt of TUI-1 followed by TUI-2
Device: TUI-1 · Device: TUI-2
Receipt of TUI-2 followed by TUI-1
Device: TUI-1 · Device: TUI-2
Provision of airflow to the nasal cavity by F\&P Tui at baseline rate
Provision of airflow to the nasal cavity by F\&P Tui at modified rate
Power spectral density of EEG
Mean PSD will be calculated across beta, alpha, delta and gamma frequency bands
Time frame: Before and 10 minutes after initiation of nasal airflow
Power spectral density of EEG between interventions
Mean PSD will be calculated across beta, alpha, delta and gamma frequency bands and compared between TUI-1 and TUI-2
Time frame: 10 minutes after initiation of nasal airflow
Coherence
Inter-regional EEG coherence will be quantified as a measure of functional connectivity
Time frame: Before and 10 minutes after initiation of nasal airflow
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fisher and Paykel Healthcare →